The Texas Heart Institute, founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education and improved patient care. Together with our clinical partner, CHI St. Luke’s Health-Baylor St. Luke’s Medical Center, we have been ranked among the top cardiovascular centers in the United States by U.S. News & World Report’s annual guide to “America’s Best Hospitals” for the past 25 years.

Texas Heart Institute is recognized internationally for research programs in cardiology, cardiovascular surgery, stem cell and gene therapy, and regenerative medicine. Our scientists and physicians are dedicated to unveiling the next discovery in treating cardiovascular disease and are spearheading some of the most innovative research in the medical field.

Additionally, the organization’s commitment to education is one that sets it apart from other institutions. With initiatives that range from postdoctoral and continued medical education to public outreach and scientific publications, Texas Heart Institute is dedicated to spreading awareness and sharing updates on ways to prevent, treat and defeat cardiovascular disease.

Our Institute has been at the forefront of cardiovascular discovery and innovation since its formation and we will continue to relentlessly pursue these outcomes until a cure for this devastating disease is found. Unlike most institutions that have a source of operating revenue, Texas Heart Institute relies on government grants, research contracts and philanthropy to cover its operating costs. In fact, donations from grateful patients, foundations, corporations, physicians, and the general public account for more than half of the Institute's annual operating budget.

The mission of the Texas Heart Institute is to reduce the devastating toll of cardiovascular disease through innovative programs in research, education and improved patient care.

Learn more about how we are pushing the boundaries of discovery and driving forward to improve cardiovascular care worldwide.